U.S. flag

An official website of the United States government

NM_007194.4(CHEK2):c.138G>A (p.Met46Ile) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Sep 2, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000216282.4

Allele description [Variation Report for NM_007194.4(CHEK2):c.138G>A (p.Met46Ile)]

NM_007194.4(CHEK2):c.138G>A (p.Met46Ile)

Gene:
CHEK2:checkpoint kinase 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
22q12.1
Genomic location:
Preferred name:
NM_007194.4(CHEK2):c.138G>A (p.Met46Ile)
HGVS:
  • NC_000022.11:g.28734584C>T
  • NG_008150.2:g.12283G>A
  • NM_001005735.2:c.138G>A
  • NM_001257387.2:c.-640G>A
  • NM_001349956.2:c.138G>A
  • NM_007194.4:c.138G>AMANE SELECT
  • NM_145862.2:c.138G>A
  • NP_001005735.1:p.Met46Ile
  • NP_001336885.1:p.Met46Ile
  • NP_009125.1:p.Met46Ile
  • NP_665861.1:p.Met46Ile
  • LRG_302t1:c.138G>A
  • LRG_302:g.12283G>A
  • LRG_302p1:p.Met46Ile
  • NC_000022.10:g.29130572C>T
  • NG_008150.1:g.12251G>A
  • NM_007194.3:c.138G>A
Protein change:
M46I
Links:
dbSNP: rs876660873
NCBI 1000 Genomes Browser:
rs876660873
Molecular consequence:
  • NM_001257387.2:c.-640G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001005735.2:c.138G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001349956.2:c.138G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_007194.4:c.138G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_145862.2:c.138G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000278651Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Sep 2, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Comprehensive analysis and ACMG-based classification of CHEK2 variants in hereditary cancer patients.

Vargas-Parra G, Del Valle J, Rofes P, Gausachs M, Stradella A, Moreno-Cabrera JM, Velasco A, Tornero E, Menéndez M, Muñoz X, Iglesias S, López-Doriga A, Azuara D, Campos O, Cuesta R, Darder E, de Cid R, González S, Teulé A, Navarro M, Brunet J, Capellá G, et al.

Hum Mutat. 2020 Dec;41(12):2128-2142. doi: 10.1002/humu.24110. Epub 2020 Oct 14.

PubMed [citation]
PMID:
32906215

Details of each submission

From Ambry Genetics, SCV000278651.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The p.M46I variant (also known as c.138G>A), located in coding exon 1 of the CHEK2 gene, results from a G to A substitution at nucleotide position 138. The methionine at codon 46 is replaced by isoleucine, an amino acid with highly similar properties. One study reports this alteration as being identified in 2/1848 individuals undergoing testing for suspected hereditary cancer (Vargas-Parra G et al. Hum Mutat, 2020 12;41:2128-2142). This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024